Sponsor:
Douglas D. Fraser
Code:
NCT06928272
Conditions
Long COVID
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Pirfenidone
Placebo for pirfenidone
Upadacitinib
Placebo for upadacitinib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-25. This information was provided to ClinicalTrials.gov by Douglas D. Fraser on 2026-04-03.